Vistagen Therapeutics Stock Price History

VTGN Stock  USD 2.93  0.09  2.98%   
Below is the normalized historical share price chart for VistaGen Therapeutics extending back to June 21, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of VistaGen Therapeutics stands at 2.93, as last reported on the 13th of November 2024, with the highest price reaching 3.05 and the lowest price hitting 2.86 during the day.
IPO Date
6th of May 2016
200 Day MA
3.9295
50 Day MA
3.0886
Beta
0.778
 
Yuan Drop
 
Covid
If you're considering investing in VistaGen Stock, it is important to understand the factors that can impact its price. VistaGen Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0836, which indicates the firm had a -0.0836% return per unit of risk over the last 3 months. VistaGen Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate VistaGen Therapeutics' Coefficient Of Variation of (1,300), risk adjusted performance of (0.05), and Variance of 5.7 to confirm the risk estimate we provide.
  
At this time, VistaGen Therapeutics' Issuance Of Capital Stock is very stable compared to the past year. As of the 13th of November 2024, Stock Based Compensation To Revenue is likely to grow to 2.15, while Common Stock Shares Outstanding is likely to drop about 11.6 M. . As of the 13th of November 2024, Price Earnings To Growth Ratio is likely to grow to 53.85, while Price To Sales Ratio is likely to drop 56.54. VistaGen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0836

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsVTGN

Estimated Market Risk

 2.38
  actual daily
21
79% of assets are more volatile

Expected Return

 -0.2
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.08
  actual daily
0
Most of other assets perform better
Based on monthly moving average VistaGen Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VistaGen Therapeutics by adding VistaGen Therapeutics to a well-diversified portfolio.
Price Book
0.7745
Enterprise Value Ebitda
(0.19)
Price Sales
95.9573
Shares Float
16.3 M
Wall Street Target Price
13

VistaGen Therapeutics Stock Price History Chart

There are several ways to analyze VistaGen Stock price data. The simplest method is using a basic VistaGen candlestick price chart, which shows VistaGen Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceAugust 26, 20243.7
Lowest PriceOctober 7, 20242.87

VistaGen Therapeutics November 13, 2024 Stock Price Synopsis

Various analyses of VistaGen Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell VistaGen Stock. It can be used to describe the percentage change in the price of VistaGen Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of VistaGen Stock.
VistaGen Therapeutics Accumulation Distribution 17,125 
VistaGen Therapeutics Price Rate Of Daily Change 0.97 
VistaGen Therapeutics Price Daily Balance Of Power(0.47)
VistaGen Therapeutics Price Action Indicator(0.07)

VistaGen Therapeutics November 13, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in VistaGen Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use VistaGen Therapeutics intraday prices and daily technical indicators to check the level of noise trading in VistaGen Stock and then apply it to test your longer-term investment strategies against VistaGen.

VistaGen Stock Price History Data

The price series of VistaGen Therapeutics for the period between Thu, Aug 15, 2024 and Wed, Nov 13, 2024 has a statistical range of 0.83 with a coefficient of variation of 6.6. The daily prices for the period are distributed with arithmetic mean of 3.17. The median price for the last 90 days is 3.1. The company experienced 1:30 stock split on 7th of June 2023.
OpenHighLowCloseVolume
11/12/2024 3.02  3.05  2.86  2.93  274,908 
11/11/2024 3.15  3.16  2.95  3.02  182,737 
11/08/2024 3.13  3.24  3.08  3.14  309,088 
11/07/2024 3.11  3.18  3.10  3.12  139,523 
11/06/2024 3.13  3.19  3.06  3.10  135,654 
11/05/2024 3.21  3.25  3.14  3.15  68,747 
11/04/2024 3.11  3.26  3.07  3.22  431,327 
11/01/2024 3.10  3.16  3.09  3.11  133,587 
10/31/2024 3.12  3.20  3.05  3.08  196,816 
10/30/2024 3.05  3.11  3.02  3.09  567,724 
10/29/2024 3.00  3.10  2.98  3.05  299,100 
10/28/2024 3.02  3.12  3.02  3.03  180,970 
10/25/2024 3.05  3.12  3.01  3.01  76,636 
10/24/2024 3.06  3.08  2.95  3.03  598,772 
10/23/2024 3.13  3.17  3.02  3.03  104,500 
10/22/2024 3.02  3.15  3.02  3.10  191,613 
10/21/2024 3.10  3.16  3.00  3.00  142,799 
10/18/2024 3.07  3.23  3.07  3.07  207,154 
10/17/2024 3.05  3.06  2.79  3.06  324,152 
10/16/2024 2.92  3.08  2.90  3.02  227,786 
10/15/2024 3.03  3.09  2.87  2.92  398,400 
10/14/2024 3.01  3.08  2.96  3.02  76,600 
10/11/2024 3.06  3.09  2.97  3.03  99,595 
10/10/2024 2.87  3.04  2.85  3.02  63,167 
10/09/2024 2.91  2.93  2.85  2.92  40,800 
10/08/2024 2.89  2.97  2.81  2.94  104,853 
10/07/2024 3.01  3.01  2.80  2.87  264,649 
10/04/2024 2.98  3.03  2.94  3.01  139,390 
10/03/2024 2.99  3.02  2.93  2.95  111,425 
10/02/2024 3.06  3.11  2.98  3.00  127,718 
10/01/2024 3.00  3.09  2.96  3.06  180,834 
09/30/2024 3.06  3.13  2.99  3.01  90,332 
09/27/2024 3.05  3.09  3.03  3.07  57,652 
09/26/2024 3.10  3.17  2.99  3.00  153,733 
09/25/2024 2.99  3.17  2.97  3.06  296,482 
09/24/2024 3.05  3.09  2.96  3.01  129,487 
09/23/2024 3.17  3.24  2.99  3.03  126,574 
09/20/2024 3.03  3.19  2.99  3.15  272,072 
09/19/2024 3.06  3.08  2.99  3.00  175,271 
09/18/2024 3.17  3.18  2.97  3.00  257,812 
09/17/2024 3.18  3.18  3.07  3.10  174,788 
09/16/2024 3.33  3.34  3.14  3.15  81,242 
09/13/2024 3.22  3.30  3.19  3.29  83,621 
09/12/2024 3.15  3.23  3.09  3.19  131,979 
09/11/2024 3.18  3.19  3.05  3.15  125,025 
09/10/2024 3.28  3.33  3.06  3.20  126,647 
09/09/2024 3.29  3.44  3.24  3.25  77,900 
09/06/2024 3.35  3.35  3.24  3.25  41,806 
09/05/2024 3.30  3.35  3.20  3.26  63,700 
09/04/2024 3.32  3.39  3.18  3.26  97,955 
09/03/2024 3.48  3.54  3.30  3.36  162,128 
08/30/2024 3.52  3.52  3.41  3.49  44,027 
08/29/2024 3.52  3.59  3.47  3.52  115,059 
08/28/2024 3.54  3.59  3.45  3.52  73,300 
08/27/2024 3.68  3.68  3.53  3.53  56,234 
08/26/2024 3.68  3.76  3.65  3.70  117,700 
08/23/2024 3.61  3.79  3.57  3.67  177,541 
08/22/2024 3.60  3.65  3.47  3.65  74,129 
08/21/2024 3.58  3.62  3.47  3.60  58,178 
08/20/2024 3.44  3.59  3.42  3.59  84,748 
08/19/2024 3.29  3.47  3.29  3.47  93,156 

About VistaGen Therapeutics Stock history

VistaGen Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for VistaGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in VistaGen Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing VistaGen Therapeutics stock prices may prove useful in developing a viable investing in VistaGen Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding19.4 M11.6 M
Net Loss-53.3 M-50.7 M

VistaGen Therapeutics Stock Technical Analysis

VistaGen Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of VistaGen Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of VistaGen Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

VistaGen Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for VistaGen Therapeutics' price direction in advance. Along with the technical and fundamental analysis of VistaGen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of VistaGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether VistaGen Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VistaGen Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vistagen Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vistagen Therapeutics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in VistaGen Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in VistaGen Stock, please use our How to Invest in VistaGen Therapeutics guide.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VistaGen Therapeutics. If investors know VistaGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VistaGen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.93)
Revenue Per Share
0.029
Quarterly Revenue Growth
(0.34)
Return On Assets
(0.39)
Return On Equity
(0.62)
The market value of VistaGen Therapeutics is measured differently than its book value, which is the value of VistaGen that is recorded on the company's balance sheet. Investors also form their own opinion of VistaGen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VistaGen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VistaGen Therapeutics' market value can be influenced by many factors that don't directly affect VistaGen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VistaGen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VistaGen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VistaGen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.